FDA Approves Auvelity for Agitation in Alzheimer’s Disease
-
By
-
-
April 30, 2026
-
3 min
By
April 30, 2026
Older patients frequently continued these medication classes 1 year after initiation
May 1, 2026
Proposed framework organizes interacting factors into four domains to guide personalized assessment
May 1, 2026
Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation
April 30, 2026